Big Promises Backed by Bad Theory
By Eric Hoffman and Stuart Newman,
Genetic Engineering & Biotechnology News
| 05. 15. 2012
Synthetic biology is the newest purported cure-all technology for remedying our social, environmental, and public health ills. As many prominent synthetic biologists proclaimed in 2007, the world “face[s] daunting problems of climate change, energy, health, and water resources. Synthetic biology offers solutions to these issues…Fifty years from now, synthetic biology will be as pervasive and transformative as is electronics today.”i
Bold claims aside, the basic assumption behind synthetic biology—that organismal complexity can be remolded with predictable outcomes using simplistic engineering tools and standardized parts—may divert scientific research and funding away from programs more beneficial to the advancement of science and the public good. In addition, the undeniable power of the technology to alter living systems also contains potential for harm.
Synthetic biology is a collection of techniques and agendas (both research and business) that includes:
- Genome-driven cell engineering: the substitution of chemically synthesized DNA or DNA analogues for their natural counterparts in order to change cell behavior and/or produce novel products;
- DNA-based device construction: the construction of DNA sequences that encode protein or RNA molecules that assemble into complex...
Related Articles
CGS is excited to announce the launch of a new anti-eugenics initiative that has been years in the making. Legacies of Eugenics in Science, Medicine, and Technology kicks off with a monthly essay series published at the Los Angeles Review of Books that will expose and contest the reemergence of eugenic ideas in contemporary health sciences, human biotechnology, public health, and medicine. Community and campus-based events featuring the authors are also being planned. The project is a collaboration among CGS...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Jorge Barrera and Rachel Houlihan, CBC | 04.09.2024
A Canadian DNA laboratory knowingly delivered prenatal paternity test results that routinely identified the wrong biological fathers — ruling out the real dads — and left a trail of shattered lives around the globe, a CBC News investigation has found...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...